Publication Cover
Spectroscopy Letters
An International Journal for Rapid Communication
Volume 35, 2002 - Issue 1
46
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

DETERMINATION OF CERTAIN ANTISPASMODIC DRUGS AS SINGLE INGREDIENT, MEBEVERINE HYDROCHLORIDE, AND IN TWO COMPONENT MIXTURES, MEBEVERINE HYDROCHLORIDE–SULPIRIDE AND ISOPROPAMIDE IODIDE–TRIFLUOPERAZINE HYDROCHLORIDE

, , &
Pages 43-61 | Received 28 Jan 2001, Accepted 03 Oct 2001, Published online: 15 Feb 2007
 

ABSTRACT

Two simple and sensitive methods are described for the quantitative determination of mebeverine hydrochloride as single ingredient. The first method depends on the application of quantitative 1H-NMR spectroscopy using deuterated chloroform and hexamine as an internal reference standard. The second method is based on measuring the native fluorescence of mebeverine hydrochloride in 0.1 N sulphuric acid at 360 nm with excitation at 290 nm. Furthermore simultaneous determinations of two component mixtures, mebeverine hydrochloride with sulpiride and isopropamide iodide with trifluoperazine hydrochloride are presented using first-derivative and second-derivative UV-spectrophotometry, respectively. The proposed methods have been successfully applied to the determination of the cited drugs in commercial tablets.

Compared with the reference methods, the proposed methods are more sensitive, with good accuracy and reproducibility.

Acknowledgments

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.